Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Cagrilintide the Phase 2 monotherapy trial studied once-weekly doses of 0.3, 0.6, 1.2, 2.4, and 4.5 mg with a dose-escalation period
Most GLP-1R agonists have gastrointestinal side effects, including nausea, vomiting, diarrhea and constipation, which may be more pronounced in elderly patients with AD and affect treatment compliance
In the patients with autoimmune/autoinflammatory diseases described in this review, co-morbidities such as metabolic syndrome and diabetes are often present
However, it significantly elevates cortisol and prolactin, creating metabolic complications
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
